Prescribing Medications in Patients with Decompensated Liver Cirrhosis

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="1"><hr/></td></tr><tr><td align="left">Chloramphenicol—higher risk of bone marrow suppression (markedly increased half life)</td></tr><tr><td align="left">Erythromycin estolate: causes cholestasis</td></tr><tr><td align="left">Tetracycline—dose related hepatotoxicity</td></tr><tr><td align="left">Antituberculous therapy in combinations, pyrazinamide</td></tr><tr><td align="left">Griseofulvin—contraindicated</td></tr><tr><td align="left">Nalidixic acid</td></tr><tr><td align="left">Nitrofurantoin prolonged use</td></tr><tr class="table-tr"><td colspan="1"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

Antibiotics to be avoided in liver disease.

International Journal of Hepatology

tab1

Table 1

Table 1: Prescribing Medications in Patients with Decompensated Liver Cirrhosis 